Please login to the form below
Longevity
This page shows the latest Longevity news and features for those working in and with pharma, biotech and healthcare.
Building and maintaining good relationships
Then of course, that’s just the beginning. If you move to the next stage, ensuring a relationship’s success and longevity takes continued effort.
Latest news
-
Novartis builds case for SMA gene therapy as FDA verdict looms
Type 1 patients often don’t survive beyond a few years of life, while type 2 patients can live into adulthood and types 3 and 4 can have normal longevity.
-
Jim Mellon's biotech Juvenescence raises $50m for anti-ageing therapies
Further partnerships in the field of longevity will be announced in coming months, and Juvenescence says it will keep adding to its staff to include a full suite of R&D
-
Daily Brief: BIO takes over from ASCO, Greece's Novartis bribery case and more
Hunt’s longevity has been despite a tumultuous period for the health service, including the steepest ever deceleration in government spending on the NHS, and angry confrontations between Hunt and junior
-
Forming a picture of health
United Nations debated questions of long-term health and longevity. ... The head of the Health and Longevity research group at the Vienna Institute of Demography within the Austrian Academy of Sciences, Marc’s research focuses on differentials in
-
GSK and Regeneron tap into UK Biobank resource
Last year, AstraZeneca entered into a similar initiative with US sequencing specialist Human Longevity led by renowned genetics researcher Craig Venter, the Wellcome Trust Sanger Institute in the UK and The
More from news
Approximately 1 fully matching, plus 42 partially matching documents found.
Latest Intelligence
-
Case study: Tackle TD for Bayer UK
To increase longevity and reach of the campaign, the Half-Time Team Talk hero video content was edited into three social content packages (shorter video clips, GIFs, static images) that were
-
Darwinian leadership in the life sciences industry
Other interviewees mentioned Vioxx and vaginal mesh as examples of the longevity of risk. ... Even though it is not strictly true to say that ours is the riskiest business, it is easily arguable that the combined size, complexity and longevity of risk in
-
Can big data give medical affairs an edge in strategic planning?
longevity of patients worldwide.
-
Toward an outcome
Despite the longevity of this view, many people struggle to see the concrete meaning of the phrase and it has become a cliché.
-
Don't you forget about me
No surprises there - pharma has long been hesitant to invest in customer insights, behaviour mapping and user experience design - all hallmarks of smart digital innovation that put longevity and ultimate impact
More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.
Latest appointments
-
Global Gene Corp appoints new chief data and technology officer
Turpaz brings over 17 years of experience across bioinformatics, IT, pharmaceuticals, digital health and genomics, most recently serving as chief information officer for Human Longevity (HLI), where he led the development
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Happy Chinese New Year 2020 - The Year of The Rat
The sign also offers advice on relationships and health, stating that although rats enjoy longevity, and can eat just about anything, they should pay attention to their diets; avoiding binge-eating
-
WHITE PAPER: Patient nonadherence – the $637bn paradox
Such undertakings may then snowball into larger, longer-term projects with scope for longevity and can be furthered with careful planning to mitigate the risk of becoming obsolete.
-
Good data is nothing without advocacy
Variety within the cohort to ensure broader reach and greater longevity of relationships. ... It also provides an exit strategy, as participants know the proposed longevity of their involvement with the programme, which increases trust and transparency.
-
OneTwoZero
OneTwoZero supports pharmaceutical companies whose mission it is to improve the quality and longevity of people’s lives.
-
GENERATION Z IS FEARFUL FOR THE FUTURE OF UK HEALTH SERVICES, SAYS NEW REPORT
Regardless of Brexit, both groups seem concerned about the longevity of the NHS with 69% of Generation Z and 72% of Baby Boomers saying they are worried about its future.
More from PMHub
Approximately 1 fully matching, plus 11 partially matching documents found.
Featured jobs
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Digital Associate Director - Medcomms
-
£65000 - £80000 per annum
-
Account director
-
Competitive salary and bonus scheme
-
Senior External Communications Lead
-
£Competitive Salary
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
- Senior Medical Writer, MedComms Agency
-
Salary TBC
-
Account Director
-
£Competitive Salary
-
Account Manager (PR)
-
Great Benefits
-
Account Director, Medical Education
-
Salary TBC
-
Account Manager
-
£Competitive Salary
-
Experienced medical editor
-
Competitive salary and bonus scheme
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
-
Publications director
-
Competitive salary and bonus scheme
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Account Director, Healthcare Communications
-
Salary TBC
Subscribe to our email news alerts
- Immutep spikes on trial of its LAG-3 drug with Keytruda
- US backs Sanofi’s ‘fast-track’ coronavirus vaccine
- Coronavirus outbreak escalation could impact drug supply chain
- Researchers discover new antibiotic using AI
- Genital herpes vaccine candidate heads for human studies
- Roche’s Herceptin/Perjeta fixed-dose combo filed with FDA
- AVENIR GLOBAL appoints global healthcare lead
- Bedrock Group bolsters team with three key appointments
- AXON recognised for ‘excellence in wellbeing’ by Great Place to Work
- Celgene’s Revlimid scores NICE approval in follicular lymphoma
- Lilly’s Cyramza narrowly clears FDA adcomm vote for first-line NSCLC
- Menlo slumps as itching drug fails mid-stage trial
Latest intelligence
- The ALS patient journey
- Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
- Equipping your medical affairs teams with solutions to navigate the healthcare landscape
- Dr Tyler Ray, OPEN Health Medical Communications...
- Can protein degraders unlock ‘undruggable’ drug targets?
- Exploring a new and exciting area of small-molecule drug discovery...
Quick links
Infographics
